Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach
Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach
复制标题
DOI:
10.1107/s0907444912050469
复制
发表时间:
2013-04-01
影响因子:
2.2
通讯作者:
Loll, Patrick J.
中科院分区:
文献类型:
--
作者:
Economou, Nicoleta J.;Zentner, Isaac J.;Loll, Patrick J.
Multidrug-resistant bacterial infections are commonly treated with glycopeptide antibiotics such as teicoplanin. This drug inhibits bacterial cell-wall biosynthesis by binding and sequestering a cell-wall precursor: a D-alanine-containing peptide. A carrier-protein strategy was used to crystallize the complex of teicoplanin and its target peptide by fusing the cell-wall peptide to either MBP or ubiquitin via native chemical ligation and subsequently crystallizing the proteinpeptideantibiotic complex. The 2.05 angstrom resolution MBPpeptideteicoplanin structure shows that teicoplanin recognizes its ligand through a combination of five hydrogen bonds and multiple van der Waals interactions. Comparison of this teicoplanin structure with that of unliganded teicoplanin reveals a flexibility in the antibiotic peptide backbone that has significant implications for ligand recognition. Diffraction experiments revealed an X-ray-induced dechlorination of the sixth amino acid of the antibiotic; it is shown that teicoplanin is significantly more radiation-sensitive than other similar antibiotics and that ligand binding increases radiosensitivity. Insights derived from this new teicoplanin structure may contribute to the development of next-generation antibacterials designed to overcome bacterial resistance.